Standout Papers
- Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer (2004)
- Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial (2007)
- Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1 (2004)
- Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group (2003)
- Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial (2007)
Immediate Impact
11 by Nobel laureates 10 from Science/Nature 105 standout
Citing Papers
Prostate cancer
2021 Standout
Challenges and Opportunities in Cancer Drug Resistance
2020 Standout
Works of A Płużańska being referenced
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1
2004 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A Płużańska | 6183 | 8129 | 2864 | 3165 | 65 | 11.4k | |
| David Olmos | 4020 | 6034 | 3095 | 3168 | 231 | 10.0k | |
| Ross A. Okimoto | 7168 | 8004 | 2659 | 4847 | 33 | 11.9k | |
| Paul N. Mainwaring | 2683 | 6748 | 2360 | 2325 | 142 | 9.0k | |
| I. Bodrogi | 3498 | 6343 | 2896 | 4241 | 77 | 10.2k | |
| Carsten Goessl | 6062 | 4332 | 1982 | 2982 | 112 | 9.4k | |
| Katsuhiko Naoki | 6146 | 7412 | 2705 | 4963 | 124 | 11.4k | |
| U. Gatzemeier | 10488 | 12028 | 1746 | 3552 | 184 | 15.9k | |
| Hidefumi Sasaki | 6305 | 7199 | 2657 | 4943 | 143 | 11.7k | |
| Isan Chen | 3565 | 6901 | 3054 | 4715 | 41 | 8.9k | |
| Steven D. Averbuch | 7926 | 7370 | 1561 | 2824 | 57 | 10.9k |
All Works
Loading papers...